Skip to main content
Healthcare

One family’s story of a life-extending medicine for pancreatic cancer

One family’s story of a life-extending medicine for pancreatic cancer

Feed excerpt — reported by STAT News

Bobby Senaha was among the first patients to use daraxonrasib, a new life-extending drug for pancreatic cancer. His wife shares what those extra months meant to his family.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.